What are Common Misconceptions in Dialysis Patient Care? Anemia and Iron Management

被引：7
作者：
Besarab, Anatole [1 ]
机构：
[1] Henry Ford Hosp, Div Nephrol & Hypertens, Dept Med, Detroit, MI 48202 USA
来源：
SEMINARS IN DIALYSIS | 2011年 / 24卷 / 05期
关键词：
RED-CELL APLASIA; HEMOGLOBIN VARIABILITY; HEMODIALYSIS-PATIENTS; SERUM FERRITIN; EPOETIN-ALPHA; ERYTHROPOIETIN; DEFICIENCY; MORTALITY; HYPORESPONSIVENESS; THROMBOCYTOSIS;
D O I：
10.1111/j.1525-139X.2011.00983.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：498 / 503
页数：6
相关论文
共 58 条
  • [1] ALI M, 1982, LANCET, V1, P652
  • [2] [Anonymous], FDA ADV COMM BRIEF D
  • [3] Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
    Babitt, Jodie L.
    Lin, Herbert Y.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : 726 - 741
  • [4] Hemoglobin variability in epoetin-treated hemodialysis patients
    Berns, JS
    Elzein, H
    Lynn, RI
    Fishbane, S
    Meisels, IS
    DeOreo, PB
    [J]. KIDNEY INTERNATIONAL, 2003, 64 (04) : 1514 - 1521
  • [5] A study of parenteral iron regimens in hemodialysis patients
    Besarab, A
    Kaiser, JW
    Frinak, S
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (01) : 21 - 28
  • [6] Besarab A, 2000, J AM SOC NEPHROL, V11, P530, DOI 10.1681/ASN.V113530
  • [7] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    Besarab, A
    Bolton, WK
    Browne, JK
    Egrie, JC
    Nissenson, AR
    Okamoto, DM
    Schwab, SJ
    Goodkin, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) : 584 - 590
  • [8] Iron Metabolism, Iron Deficiency, Thrombocytosis, and the Cardiorenal Anemia Syndrome
    Besarab, Anatole
    Hoerl, Walter Hermann
    Silverberg, Donald
    [J]. ONCOLOGIST, 2009, 14 : 22 - 33
  • [9] Amino acid sequence homology of thrombopoietin and erythropoietin may explain thrombocytosis in children with iron deficiency anemia
    Bilic, E
    Bilic, E
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (08) : 675 - 676
  • [10] Continuous intravenous sodium ferric gluconate improves efficacy in the maintenance phase of EPOrHu administration in hemodialysis patients
    Bolaños, L
    Castro, P
    Falcón, TG
    Mouzo, R
    Varela, JM
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2002, 22 (01) : 67 - 72
123456